Are you interested in presenting your research to an international audience?

We encourage you to submit an abstract for the World Meeting on Sexual Medicine, which will be held virtually November 19-21, 2021.

The ISSM Scientific Committee welcomes the submission of abstracts for oral, video and poster presentations in the following categories:

• Basic science
• Psycho-socio-cultural aspects of sexuality
• Epidemiology, risk factors and the prevention of sexual problems
• ED: epidemiology
• ED: medical therapy
• ED: surgical therapy
• ED: diagnosis
• Peyronie’s disease
• Sexual desire and its associated problems
• Sexual arousal and its associated problems
• Orgasm and its associated problems
• Ejaculation and its associated problems
• Sexual and genital pain
• Androgens and sexual endocrinology
• Sexual dermatology and sexually transmitted infection
• Sex and other biomedical issues
• Sex and relationship therapy
• Sexual identity (orientation), gender identity and sexual preference
• Fertility
• Ethics and sexual medicine
• History of sexual medicine
• Other aspects of sexual medicine

Please note that the submission deadline is July 15, 2021. Learn more. 

Patients with high blood pressure may be hesitant to undergo intensive anti-hypertensive therapy due to concerns about sexual side effects. 

However, new research suggests that intensive therapy does not affect sexual function any more than standard therapy does.

The study involved 1,268 men and 613 women who were participants in the larger Systolic Blood Pressure Intervention Trial (SPRINT). Some participants underwent intensive anti-hypertensive therapy with a systolic blood pressure target of less than 120 mm Hg. Others had standard therapy with a target of less than 140 mm Hg.

Both men and women did experience sexual side effects, but these outcomes did not appear linked to therapy type. 

The study was published in February in the American Journal of Hypertension. See more details.